产品封面图

NCI-H69

收藏
  • 询价
  • ATCC
  • 美国
  • NCI-H69
  • 2025年11月24日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 询价记录
    • 文献和实验
    • 技术资料
    • 供应商

      复祥生物

    • 运输方式

      常温 干冰

    • 生长状态

      良好

    • 库存

      大量

    Designations: NCI-H69 [H69]
    Depositors: AF Gazdar
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: suspension, multicell aggregates
    Organism: Homo sapiens
    Morphology: floating aggregates
    Source: Organ: lung
    Disease: carcinoma; small cell lung cancer
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Receptors: insulin-like growth factor II (IGF II)
    Tumorigenic: Yes
    Oncogene: myc +; myb +; fes +; fms +; raf +; ras +
    DNA Profile (STR): CSF1PO: 10, 12
    D13S317: 12
    D16S539: 11
    D5S818: 11, 13
    D7S820: 9
    THO1: 8, 9
    TPOX: 10
    vWA: 16, 17
    Amelogenin: XY
    Cytogenetic Analysis: modal number = 76 to 78; range = 40 to 87
    This is an aneuploid human male cell line. Monosomy of many of the normal chromosomes is noted as well as bisomy in this subtetraploid cell line; however, translocations and deletions involving many of the missing chromosomes are noted, and these chromosomal rearrangements appear to be stable and generally paired. Twelve marker chromosomes were identified including: der(16)t(1;16)(q21;q23), der(22)t(4;22)(q12;q13), der(12)t(11;12)(q23;p12), del(17)(p11), der(19)t(5;19)(?q21;q13) and others.
    Isoenzymes: AK-1, 1
    ES-D, 2
    G6PD, B
    GLO-I, 1-2
    Me-2, 1
    PGM1, 2
    PGM3, 1
    Age: 55 years adult
    Gender: male
    Ethnicity: Caucasian
    Comments: This cell line is aneuploid, will form colonies in soft agar and retains small cell carcinoma morphology and ultrastructure as well as APUD cell characteristics.
    The cells grow in aggregates, thus cell counts are not accurate.
    The cells stain positively for cytokeratins.
    The line can be adapted to grow in shaker flask or spinner flask systems.
    The N-myc gene is amplified, and there is expression of the mRNA and protein.
    C-myc mRNA, but not protein, is expressed at a low level.
    There is expression of c-myb, v-fes, v-fms, c-raf 1, Ha-ras, Ki-ras and N-ras mRNA.
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
    Temperature: 37.0°C
    Subculturing: Protocol: Attached cells can be detached by shaking flask Allow aggregates to settle to the bottom of the flask, remove and discard the supernatant medium. Add fresh medium, disperse cells by gentle pipetting and dispense into new flasks. Do not break down aggregates. Subculture every 6 to 8 days.
    Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:4 is recommended
    Medium Renewal: 2 times weekly
    Preservation: Freeze medium: Complete growth medium, 95%; DMSO, 5%
    Storage temperature: liquid nitrogen vapor temperature
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
    recommended serum:ATCC 30-2020
    derivative:ATCC CRL-11351
    purified DNA:ATCC HTB-119D
    References: 1805: Little CD, et al. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306: 194-196, 1983. PubMed: 6646201
    22250: Bepler G, et al. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer. Oncogene 4: 45-50, 1989. PubMed: 2536917
    22446: Schardt C, et al. Characterization of insulin-like growth factor II receptors in human small cell lung cancer cell lines. Exp. Cell Res. 204: 22-29, 1993. PubMed: 8380141
    22465: Broers JL, et al. Spontaneous changes in intermediate filament protein expression patterns in lung cancer cell lines. J. Cell Sci. 91: 91-108, 1988. PubMed: 2473086
    22869: Rygaard K, et al. Expression of myc family oncoproteins in small-cell lung-cancer cell lines and xenografts. Int. J. Cancer 54: 144-152, 1993. PubMed: 8386707
    23036: Gazdar AF, et al. Establishment of continuous, clonable cultures of small-cell carcinoma of lung which have amine precursor uptake and decarboxylation cell properties. Cancer Res. 40: 3502-3507, 1980. PubMed: 6108156
    23037: . . Cancer Res. 40: 4556-4563, 1980.
    23056: Carney DN, et al. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res. 45: 2913-2923, 1985. PubMed: 2985257
    23057: Gazdar AF, et al. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Cancer Res. 45: 2924-2930, 1985. PubMed: 2985258
    23065: Kiefer PE, et al. Amplification and expression of protooncogenes in human small cell lung cancer cell lines. Cancer Res. 47: 6236-6242, 1987. PubMed: 2824028
    23080: Hensel CH, et al. Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res. 50: 3067-3072, 1990. PubMed: 2159370
    24389: . . Lung Cancer 4: 155-161, 1988.
    32276: Cairns P, et al. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions. Cancer Res. 57: 5356-5359, 1997. PubMed: 9393760
    32488: Geiger T, et al. Antitumor activity of a PKC-alpha antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted into nude mice. Anticancer Drug Des. 13: 35-45, 1998. PubMed: 9474241

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标文献和实验
    相关实验
    • 人肺癌细胞(spc-A1、NCI-H446)传代

      都是贴壁细胞,在消化传代过程中,步骤如下:倒尽旧的培养液->用无血清的培养基清洗一两次->加入一定量的胰酶,置于37度培养箱中5--10分钟,使细胞悬浮->显微镜下观察,待细胞大部分变圆时,回到超静台->加入一定量的含血清的新培养液,以终止胰酶作用->反复吹打细胞->再置显微镜下观察,直到细胞全部悬浮起来->吸出一部分加入新的培养瓶中->最后再补充加入一定量新的培养液。注意: 1、吹细胞时尽量多吹边角儿,此处细胞生长的多。2、吸出细胞前要混匀,可以剧烈震荡培养瓶。3、我们用的是DMEM

    • [D-Arg6, D-Trp7,9, NmePhe8]-Substance P (6-11) Activates JNK and Induces Apoptosis in Small Cell Lung Cancer Cells via an Oxidant-Dependent Mechanism

      for the treatment of SCLC (1 ,2) . Although antagonist G blocks SCLC cell growth (IC50 = 24.5 � 1.5 and 38.5 � 1.5 μM for the H69 and H510 cell lines, respectively), its exact mechanism of action is unclear. Factors affecting the balance between SCLC cell

    • Science 子刊揭露遗传性肺癌亚型,我们离肺癌精准医疗还有多远?

      Medicine 2021 年 1 月 27 号,来自美国国家癌症研究所(NCI)的 Anish Thomas 教授带领团队在 Science 子刊 Science Translational Medicine 上发表了题为 Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair–targeted therapies 的研究

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥900
    上海泽叶生物科技有限公司
    2025年12月30日询价
    ¥900
    上海淳麦生物科技有限公司
    2025年07月16日询价
    询价
    蒂科(上海)生物科技有限公司
    2025年07月14日询价
    ¥880
    武汉华尔纳生物科技有限公司
    2025年07月11日询价
    NCI-H69
    询价